Trial Profile

Trial of NM-505 for treatment of type 2 diabetes

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 May 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NM 505 (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

13 May 2015 USFDA has responded positively to the company's pre-IND request to use the 505(b)(2) abbreviated pathway.
09 Apr 2015 New trial record
07 Apr 2015 According to a MicroBiome Therapeutics media release, this trial is planned in order to allow the company to seek FDA marketing approval via the expedited 505(b)(2) regulatory pathway.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com